Major pharmaceutical stocks were down in recent Wednesday trading after multiple news outlets reported that President Donald Trump said Tuesday the US will impose a significant tariff on pharmaceutical imports.
Shares of Johnson & Johnson (JNJ) dropped 2.4%, Pfizer (PFE) slid 2.5%, Biogen (BIIB) declined 1.9%, Bristol-Myers Squibb (BMY) slipped 4.4%, Eli Lilly (LLY) lost 3%, Merck (MRK) retreated 2.7% and Amgen (AMGN) fell 2.6%.
Also on Wednesday, the Chinese Finance Ministry said China has increased tariffs on imports from the US to 84% from 34%, starting April 10, in response to Trump's decision to increase a "reciprocal tariff" on Chinese goods.
On the same day, Bloomberg reported that the European Union has adopted tariffs that will hit about 21 billion euros ($23.25 billion) worth of US goods in response to the 25% duties Trump imposed in March on the bloc's steel and aluminum exports.
Price: 146.43, Change: -3.57, Percent Change: -2.38
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.